Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Inventory: 2010-2025

Historic Change in Inventory for Cumberland Pharmaceuticals (CPIX) over the last 15 years, with Sep 2025 value amounting to -$630,409.

  • Cumberland Pharmaceuticals' Change in Inventory fell 468.77% to -$630,409 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 million, marking a year-over-year decrease of 499.99%. This contributed to the annual value of -$2.4 million for FY2024, which is 10506.59% down from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Change in Inventory stood at -$630,409, which was up 25.90% from -$850,797 recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Change in Inventory peaked at $1.6 million during Q3 2022, and registered a low of -$2.3 million during Q1 2022.
  • Moreover, its 3-year median value for Change in Inventory was -$630,409 (2025), whereas its average is -$439,442.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Change in Inventory surged by 756.09% in 2022, and later slumped by 1,073.11% in 2024.
  • Cumberland Pharmaceuticals' Change in Inventory (Quarterly) stood at -$2.3 million in 2021, then spiked by 118.92% to $427,803 in 2022, then climbed by 3.20% to $441,498 in 2023, then tumbled by 402.63% to -$1.3 million in 2024, then plummeted by 468.77% to -$630,409 in 2025.
  • Its Change in Inventory stands at -$630,409 for Q3 2025, versus -$850,797 for Q2 2025 and -$967,399 for Q1 2025.